199 related articles for article (PubMed ID: 23453508)
1. L6. Eosinophilic granulomatosis with polyangiitis: future therapies.
Moosig F
Presse Med; 2013 Apr; 42(4 Pt 2):510-2. PubMed ID: 23453508
[No Abstract] [Full Text] [Related]
2. L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cordier JF; Cottin V; Guillevin L; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME
Presse Med; 2013 Apr; 42(4 Pt 2):507-10. PubMed ID: 23490637
[No Abstract] [Full Text] [Related]
3. Can ANCA differentiate eosinophilic granulomatosis with polyangiitis (Churg-Strauss) from idiopathic hypereosinophilic syndrome?
Zwerina J; Strehl JD; Beyer C; Schett G
Clin Exp Rheumatol; 2013; 31(6):989-90. PubMed ID: 24144017
[No Abstract] [Full Text] [Related]
4. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.
Umezawa N; Kohsaka H; Nanki T; Watanabe K; Tanaka M; Shane PY; Miyasaka N
Mod Rheumatol; 2014 Jul; 24(4):685-7. PubMed ID: 24517553
[TBL] [Abstract][Full Text] [Related]
6. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
7. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
[No Abstract] [Full Text] [Related]
8. S3. Rituximab for ANCA-associated vasculitides: the French experience.
Charles P; Guillevin L
Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
[No Abstract] [Full Text] [Related]
9. Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome.
Moosig F; Gross WL; Herrmann K; Bremer JP; Hellmich B
Ann Intern Med; 2011 Sep; 155(5):341-3. PubMed ID: 21893636
[No Abstract] [Full Text] [Related]
10. S1. Rituximab for ANCA-associated vasculitis: the experience in the United States.
Clain JM; Specks U
Presse Med; 2013 Apr; 42(4 Pt 2):530-2. PubMed ID: 23477713
[No Abstract] [Full Text] [Related]
11. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
12. [Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes?].
Hellmich B; Holl-Ulrich K; Merz H; Gross WL
Internist (Berl); 2008 Mar; 49(3):286-96. PubMed ID: 18214408
[TBL] [Abstract][Full Text] [Related]
13. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
14. Churg-Strauss syndrome.
Keogh KA; Specks U
Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
[TBL] [Abstract][Full Text] [Related]
16. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
[No Abstract] [Full Text] [Related]
17. [Churg-Strauss syndrome and antineutrophil cytoplasmic antibodies].
Lafont A; Olivé A; Abad E; Coll-Cantí J
Med Clin (Barc); 1997 May; 108(20):797. PubMed ID: 9265086
[No Abstract] [Full Text] [Related]
18. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
19. [ANCA-associated vasculitis. New concepts and strategies in therapy].
de Groot K; Haubitz M; Haller H
Internist (Berl); 2000 Oct; 41(10):1112-9. PubMed ID: 11084898
[No Abstract] [Full Text] [Related]
20. B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement.
Grigoriou A; Endean A; Sangle SR; D'Cruz DP
Rheumatology (Oxford); 2014 Oct; 53(10):1741. PubMed ID: 25096603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
